Pharmacologic influences on human ovarian contractions

Area of Science:

• Reproductive Biology
• Pharmacology
• Gynecology

Background:

• Ovarian motility and its regulation are not fully understood.
• Investigating the contractile properties of ovarian tissues is crucial for understanding reproductive physiology.

Purpose of the Study:

• To explore spontaneous motility in ovarian follicles, stroma, and capsule.
• To examine the contractile responses of these ovarian structures to various smooth muscle-stimulating agents.

Main Methods:

• Isolated ovarian follicles, stroma, and capsule from premenopausal and menopausal women were used.
• Spontaneous motility was recorded.
• Pharmacologic contractile reactivity was assessed using prostaglandins (E1, E2, F2alpha), norepinephrine, 5-hydroxytriptamine, acetylcholine, phenylephrine, and phentolamine.

Main Results:

• Ovarian capsule and stroma strips demonstrated spontaneous motility in both menopausal and nonmenopausal women.
• Phenylephrine, norepinephrine, acetylcholine, 5-hydroxytriptamine, and prostaglandin F2alpha induced tonic contractions, while prostaglandin E1 had an inhibitory effect.
• Stromal strips from premenopausal women showed greater reactivity to norepinephrine than those from menopausal women.
• Ovarian follicles lacked spontaneous motility but contracted in response to norepinephrine, an effect blocked by phentolamine (alpha-adrenergic receptors).
• Acetylcholine, prostaglandin F2alpha, and prostaglandin E2 increased follicular resting tension, whereas prostaglandin E1 inhibited both basal tone and prostaglandin F2alpha-induced contractions.

Conclusions:

• Ovarian stroma and capsule possess inherent motility.
• Ovarian follicles respond to specific pharmacologic agents, notably norepinephrine via alpha-adrenergic receptors.
• Prostaglandins exhibit differential effects on ovarian contractility, with PGE1 being inhibitory and PGF2alpha and PGE2 being stimulatory.